Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
American journal of clinical oncology2000Ahmed S, Vaitkevicius VK, Zalupski MM, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
AdenocarcinomaAdultAgedAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCA-19-9 AntigenCaffeineCisplatinConfidence IntervalsCytarabineFemaleFluorouracilHumansMaleMiddle AgedNeutropeniaPancreatic NeoplasmsPhosphodiesterase InhibitorsRemission InductionSurvival RateThrombocytopenia
DOI 10.1097/00000421-200008000-00022
PMID 10955876
原文・出典を見る →